These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24454000)

  • 21. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.
    Ma MW; Gao XS; Gu XB; Xie M; Cui M; Zhang M; Liu L; Yin H; Chen LQ
    World J Surg Oncol; 2018 Aug; 16(1):172. PubMed ID: 30119684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
    Jiang W; Verma V; Haque W; Moreno AC; Koshy M; Butler EB; Teh BS
    Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31504359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
    Furuta M; Yokota T; Tsushima T; Todaka A; Machida N; Hamauchi S; Yamazaki K; Fukutomi A; Kawai S; Kawabata T; Onozawa Y; Yasui H
    Jpn J Clin Oncol; 2019 Oct; 49(10):910-918. PubMed ID: 31219161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
    Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
    Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.
    Li W; Chen P; Zhang N; Song T; Wu S
    Oncologist; 2019 Apr; 24(4):461-e136. PubMed ID: 30850562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.
    Ogawa K; Ishikawa H; Hisakura K; Hiroshima Y; Moriwaki T; Yamada T; Yamamoto Y; Akashi Y; Owada Y; Ohara Y; Enomoto T; Furuya K; Doi M; Shimomura O; Takahashi K; Hashimoto S; Sakurai H; Oda T
    Int J Clin Oncol; 2021 Oct; 26(10):1856-1863. PubMed ID: 34241725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy.
    Chi D; Chen B; Guo S; Bai K; Ma H; Hu Y; Li Q; Zhu Y
    Aging (Albany NY); 2021 Mar; 13(6):8408-8420. PubMed ID: 33713398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
    BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
    BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
    Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
    Yeom JG; Kim JH; Kim JW; Cho Y; Lee IJ; Lee CG; Chun J; Youn YH; Park H
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
    Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
    Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report.
    Yura M; Koyanagi K; Hara A; Hayashi K; Tajima Y; Kaneko Y; Fujisaki H; Hirata A; Takano K; Hongo K; Yo K; Yoneyama K; Tamai Y; Dehari R; Nakagawa M
    World J Clin Cases; 2021 Apr; 9(12):2801-2810. PubMed ID: 33969062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
    Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
    Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer.
    Shimonosono M; Sasaki K; Tsuruda Y; Noda M; Uchikado Y; Arigami T; Matsushita D; Mori S; Kurahara H; Nakajo A; Ohtsuka T
    Anticancer Res; 2022 Aug; 42(8):3953-3961. PubMed ID: 35896243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume.
    Duarte MBO; Pereira EB; Lopes LR; Andreollo NA; Carvalheira JBC
    JCO Glob Oncol; 2020 Jun; 6():828-836. PubMed ID: 32552112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.